Cadila Pharmaceuticals expands oncology portfolio, launches Tarzed
Tarzed is available as 440 mg injection
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Indian pharma industry estimated to grow nine to 11 per cent in 2021-22: ICRA
The normalisation of the base and pricing pressures in the US market were the major reasons for slowing growth momentum in Q2…
Entod Pharmaceuticals set to launch Molentod for treating COVID-19
Molentod will be available at retail chemists, pharmacy chains, hospitals and online stores across India at an affordable price to…
CPhI Worldwide releases pharma market predictions for 2022
The findings suggest a robust and prosperous year ahead for the contract services industry
Dr Reddy’s to launch generic COVID-19 Merck drug at about 50 cents a pill
The overall cost for a patient treated with a five-day course of 40 capsules of the generic drug, to be sold under brand name…
WuXi STA passes first US FDA drug product pre-approval inspection at its Shanghai Waigaoqiao site
During the five-day inspection from 22nd to 26th October, 2021, the FDA inspector conducted a comprehensive onsite assessment,…
We aim to build a nutrition-literate planet with focus on oncological nutrition
Raktim Chattopadhyay, Founder and CEO, Esperer Nutrition, talks to Akanki Sharma about the contribution his company is making…
Piramal Pharma Solutions expands in-vitro biology capabilities at Ahmedabad Discovery Services Site
The benefits of this new investment will be seen in an improved experience for PPS discovery services customers
Kintor Pharma announces first patient dosing of phase-III clinical trial of Pyrilutamide to treat…
On 24th November, 2021, Kintor Pharma announced that China's National Medical Products Administration (NMPA) greenlighted the…
Interval between Moderna COVID-19 vaccine second shot and booster still six months: FDA
"Right now, if you got J&J, you get a booster after two months, if you got Pfizer as your primary series you can get a booster…
Alembic Pharmaceuticals receives US FDA approval for Doxycycline Hyclate delayed-release tablets
The approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product Doryx tablets, 75 mg, 100 mg, 150 mg…
Eris’s revenue has grown six times since FY11
V Krishnakumar, Executive Director and Chief Operating Officer, Eris Lifesciences, informs Akanki Sharma about the company’s…
Why we need an Aatmanirbhar booster strategy
An Aatmanirbhar booster strategy will save lives. As a bonus, it will also boost long term development programmes at local…
Britain approves Pfizer’s anti-viral COVID-19 pill Paxlovid
Based on data, the pill, Paxlovid, is most effective when taken during the early stages of COVID-19, Britain's Medicines and…
Novavax submits final data to US FDA as prerequisite to EUA application request for COVID-19 vaccine
Novavax has filed the complete CMC data package, which leverages Novavax's manufacturing partnership with the Serum Institute of…
Researchers at Technical University of Munich investigate mRNA nanoparticles
Researchers at the Heinz Maier-Leibnitz Zentrum (MLZ) used the high neutron flux available in Garching to characterise various…
Zydus Cadila receives tentative approval from US FDA for Pimavanserin capsules
Pimavanserin is an atypical antipsychotic and is indicated for the treatment of hallucinations and delusions associated with…
Emcure Pharmaceuticals to launch oral COVID-19 drug in a week’s time in India
A toll-free helpline to be set up to help doctors and patients
Briton Pharma’s anti-COVID drug Molviton to hit Indian market next week
Each pack will have 40 capsules as general recommended dosage is 800 mg twice/day for five days
Torrent Pharma to launch Molnupiravir under the brand name Molnutor in India
Earlier this year, MSD inked a non-exclusive voluntary licensing pact with Torrent Pharma, granting rights to the latter for…